Tandem autologous plus non-myeloablative allogeneic stem cell transplantation in relapsed multiple myeloma: an Australian joint report from the Alfred and Myeloma and Related Diseases Registry

被引：0
|
作者：
Tedjaseputra, Aditya [1 ]
Das, Tongted [1 ]
Wellard, Cameron [2 ]
Spencer, Andrew [3 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Transfus Res Unit, Clayton, Vic, Australia
[3] Monash Univ, Alfred Hlth, Clayton, Vic, Australia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-218
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [31] Autologous and allogeneic stem cell transplantation in multiple myeloma (MM).
    Worel, N
    Keil, F
    Loidolt, H
    Rabitsch, W
    Knöbl, P
    Drach, J
    Kalhs, P
    Höcker, P
    Greinix, HT
    BLOOD, 1999, 94 (10) : 407B - 407B
  • [32] Multiple myeloma: Allogeneic or autologous hematopoietic stem cell transplantation?
    Ghavamzadeh, A.
    Kasaeian, A.
    Alimoghaddam, K.
    Ranjbar, H.
    Mousavi, A.
    Bahar, B.
    Kamranzadeh, H.
    Vaezi, M.
    Maheriazar, R.
    Jahani, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S466 - S466
  • [33] Multiple Myeloma Combined allogeneic / autologous Stem Cell Transplantation
    Ruchalla, Elke
    TRANSFUSIONSMEDIZIN, 2012, 2 (03) : 126 - 126
  • [34] Multiple Myeloma: Allogeneic or Autologous Hematopoietic Stem Cell Transplantation?
    Vaezi, Mohammad
    Tavakkoli, Sahar
    Kasaeian, Amir
    Alimoghadam, Kamran
    Kamranzadeh, Hosein
    Mousavi, Seyed Asadillah
    Ghavamzadeh, Ardeshir
    BONE MARROW TRANSPLANTATION, 2018, 53 : 653 - 654
  • [35] Tandem allogeneic stem cell transplantation (alloSCT) for patients with leukemia who relapsed following non-myeloablative stem cell transplantation (NST)
    Nagler, A
    Or, R
    Varadi, G
    Shapira, M
    Slavin, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S288 - S289
  • [36] Tandem Autologous Stem Cell Transplantation in Chemorefractory Multiple Myeloma
    Garnett, Catherine
    Giles, Chrissy
    Ahmed, Osman
    Lasa, Maialen
    Auner, Holger W.
    MacDonald, Donald
    Marks, Sasha
    Marin, David
    Milojkovic, Dragana
    Pavlu, Jiri
    Bua, Marco
    Abdalla, Saad
    Kanfer, Edward J.
    Apperley, Jane
    Rahemtulla, Amin
    BLOOD, 2012, 120 (21)
  • [37] Efficacy of bortezomib therapy for extrarnedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation
    Patriarca, FE
    Prosdocimo, S
    Tomadini, V
    Vasciaveo, A
    Bruno, B
    Fanin, B
    HAEMATOLOGICA, 2005, 90 (02) : 278 - 279
  • [38] Non-myeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
    Gerull, S
    Probst, S
    Ho, AD
    Goldschmidt, H
    Goerner, M
    Schaefer, H
    BLOOD, 2003, 102 (11) : 475B - 475B
  • [39] Long-term outcome of autologous and myeloablative allogeneic stem cell transplantation for Multiple Myeloma.
    Kuruvilla, J
    Nevill, TJ
    Nitta, J
    Le, A
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Shepherd, JD
    BLOOD, 2003, 102 (11) : 475A - 475A
  • [40] Non-myeloablative allogeneic stem cell transplantation is feasible in multiple myeloma patients with end-stage renal disease.
    Steel, E
    Gadisseur, APA
    Van de Velde, ALR
    Schroyens, WA
    Zachee, P
    Berneman, ZN
    BLOOD, 2003, 102 (11) : 430B - 431B
12345